ABEO
ABEO
NASDAQ · Biotechnology

Abeona Therapeutics Inc

$6.18
+0.52 (+9.19%)
As of Jun 30, 10:20 PM ET ·
Analyst Consensus
Strong Buy
12
Analysts
Moderate
Coverage
Buy 11 92%
Hold 1 8%
Sell 0 0%
Price Target
Analyst Price Target +128.0% upside
Low Target $7.81
Average Target $14.09
High Target $15.42
Current Price $6.18
Current
$6.18
Target
$14.09
$7.81 $14.09 avg $15.42
Scenario Analysis
Bear Case
$7.81
26.4%
Low target
Base Case
$14.09
+128.0%
Avg target
Bull Case
$15.42
+149.5%
High target
Risk/Reward
5.7x
Highly favorable
Price in Context
52-Week High
$7.54
-18.0% from high
52-Week Low
$4.00
+54.5% from low
Target vs 52W High
$14.09
+86.9% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 40 78% $257.58 +2.4%
AMGN
Amgen Inc
Hold 44 50% $190.87 -47.3%
GILD
Gilead Sciences Inc
Strong Buy 39 82% $362.68 +187.1%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 40 83% $438.34 -11.8%
REGN
Regeneron Pharmaceuticals
Buy 38 71% $76.80 -87.7%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 37 76% $102.31 -66.0%
RVMD
Revolution Medicines Inc
Strong Buy 27 96% $114.11 -39.1%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -47.4%